The IMA Group is a well-established health care company that has been in operation since 1990. With the mission of enhancing the livelihood and productivity of individuals and organizations navigating challenging periods of health, work, and disability, the company has gained a solid reputation in the industry. The company operates through two divisions - Evaluation Services including Government and Payer, and a Clinical Research Site Network. The Evaluation Services division provides medical and psychological evaluations and ancillary services to federal, state, and local governments and agencies, commercial insurers, TPAs, and corporate clients.
The Clinical Research Site Network focuses on Phase II, III, and IV clinical trials in multiple therapeutic areas through a nationwide multi-site network. The company's extensive reach with thousands of licensed providers and over 150 offices nationwide enables it to serve national needs while maintaining a regional focus.
The IMA Group's recent Private Equity Round investment at 01 January 2018 was led by Centre Partners, showcasing the confidence that renowned investors have in the company's potential for growth and impact in the health care industry.
With its strong dedication to contributing to the development of new medical treatments and clinical advancements, The IMA Group stands out as a key player in the health care sector, poised for further expansion and innovation.